Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: A phase II study of the Southwest Oncology Group

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 610-615

  Scudder, Sidney A ^a   Liu, P Y ^b   Wilczynski, Sharon P ^c   Smith, Harriet O ^d   Jiang, Caroline ^b   Hallum III, Alton V ^e   Smith, Gregory B ^f   Hannigan, Edward V ^g   Markman, Maurie ^h   Alberts, David S ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SW Oncology Group Statistical Center ^*  (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h UNIVERSITY OF TEXAS   (United States)

Author keywords

Amifostine; Carboplatin; Paclitaxel

Indexed keywords

AMIFOSTINE; CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEHYDRATION; DIARRHEA; DISEASE COURSE; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; EMBOLISM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPERGLYCEMIA; INFECTION; LUNG EMBOLISM; MEASUREMENT; NAUSEA; NEUTROPENIA; ONCOLOGY; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM FISTULA; RECURRENT CANCER; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TOXICITY; VAGINA DISEASE;

EID: 13844281651     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.024     Document Type: Article

References (23)

1. J.T. Thigpen, H.J. Buchsbaum, C. Mangan, and J.A. Blessing Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Cancer Treat Rep. 63 1979 21 27
2. J.C. Seski, C.L. Edwards, J. Herson, and F.N. Rutledge Cisplatin chemotherapy for disseminated endometrial cancer Obstet. Gynecol. 59 1982 225 228
3. J.T. Thigpen, J.A. Blessing, H. Homesley, W.T. Creasman, and G. Sutton Phase II trial of cisplatin as first line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Gynecol. Oncol. 33 1989 68 70
4. J.H. Edmonson, J.E. Krook, and J.F. Hilton Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma Gynecol. Oncol. 28 1987 20 24
5. G. Deppe, C.J. Cohen, and H.W. Bruckner Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy Gynecol. Oncol. 10 1980 51 54
6. J.C. Seski, C.L. Edwards, J. Herson, and F.N. Rutledge Cisplatin chemotherapy for disseminated endometrial cancer Obstet. Gynecol. 59 1982 225 228
7. J.T. Thigpen, M.F. Brady, H.D. Homesley, J. Malfetano, B. DuBeshter, and R.A. Burger Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study J. Clin. Oncol. 22 2004 3902 3908
8. G.F. Fleming, V.L. Brunetto, D. Cella, K.Y. Look, G.C. Reid, and A.R. Munkarah Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J. Clin. Oncol. 22 2004 2159 2166
9. H.G. Ball, J.A. Blessing, S.S. Lentz, and D.G. Mutch A phase II trial of paclitaxel in patients with advanced or recurrent denocarcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol. Oncol. 62 1996 278 281
10. S. Lincoln, J.A. Blessing, R.B. Lee, and T.F. Rocereto Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study Gynecol. Oncol. 88 2003 277 281
11. M.A. Dimopoulos, C.A. Papadimitriou, and V. Georgoulias Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study Gynecol. Oncol. 78 2000 52 57
12. H.J. Long, D.M. Pfeifle, H.S. Wieand, J.E. Krook, J.H. Edmonson, and J.C. Buckner Phase II evaluation of carboplatin in advanced endometrial carcinoma J. Natl. Cancer Inst. 80 1988 276 278
13. J.B. Green III, S. Green, D.S. Alberts, R. O'Toole, E.A. Surwit, and J.W. Noltimer Carboplatin therapy in advanced endometrial cancer Obstet. Gynecol. 75 1990 696 700
14. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J. Clin. Oncol. 21 2003 3194 3200
15. C.M. Spencer, and K.L. Goa Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector Drugs 50 1995 1001 1031
16. R.L. Capizzi The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol) Eur. J. Cancer 32A Suppl. 4 1996 S5 S16
17. G.T. Budd, R. Ganapathi, and L. Bauer Phase I study of WR-2721 and carboplatin Eur. J. Cancer 29A 1993 1122 1127
18. R.L. Capizzi, B.J. Scheffler, and P.S. Schein Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy Cancer 72 Suppl. 11 1993 3495 3501
19. G.T. Budd, R. Ganapathi, and D.J. Adelstein Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors Cancer 80 1997 1134 1140
20. G. Kemp, P. Rose, and J. Lurain Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer J. Clin. Oncol. 14 1996 2101 2112
21. F.V. Price, R.P. Edwards, J.L. Kelley, A.J. Kunschner, and L.A. Hart A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report Semin. Oncol. 24 5 Suppl. 15 1997 S15-78 S15-82
22. T. Nakamura, Y. Onishi, F. Yamamoto, S. Kouno, Y. Maeda, and M. Hatae Evaluation of paclitaxel and carboplatin in patients with endometrial cancer Gan To Kagaku Ryoho 27 2000 257 262
23. P.J. Hoskins, K.D. Swenerton, and J.A. Pike Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study J. Clin. Oncol. 19 2001 4048 4053